GlassScriptPhysician profile
Melissa Simmons
NPI 1467100875
$3,205.07
in general payments reported to CMS, 2019-2025
16 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,152 · 2023: $922 · 2024: $469 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023 · Education: $30.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.30 |
| Education | $30.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,286.90 | 2022-2025 | |
| Uswm, LLC | $546.12 | 2022-2023 | Zimhi, Lucemyra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $519.98 | 2022-2025 | Caplyta |
| Alkermes, INC. | $375.25 | 2022-2025 | Aristada, Lybalvi, Aristada Initio |
| Indivior INC. | $134.12 | 2022 | |
| Currax Pharmaceuticals LLC | $68.47 | 2022-2023 | Contrave, Nexlizet, Nexletol |
| Idorsia Pharmaceuticals US INC | $45.63 | 2022-2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $43.45 | 2022-2023 | Hetlioz |
| Boston Scientific Corporation | $38.49 | 2023 | Avvigo Guidance System, Rotapro |
| Supernus Pharmaceuticals, INC. | $30.08 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $26.32 | 2023 | Abilify Maintena, Rexulti |
| Bioxcel Therapeutics, INC. | $25.00 | 2023 | Igalmi |
| Axsome Therapeutics, INC. | $18.48 | 2023 | Auvelity |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.32 | 2025 | Rejoyn |
| Neos Therapeutics, LP | $15.98 | 2025 | Exxua |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.